How much funding is available in total?

$5,600,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.

FederalClosing soonFixed dateDefense Health Agency Contracting Activity - DHACA

DoW Ovarian Cancer, Clinical Trial Award

Per-recipient award not stated for unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "additional information on eligibility", closing Oct 1, 2026.

Official page Sign in to trackVerified2026-09-04

Open to any applicantScience, Technology, Research & Development

In one sentence

DoW Ovarian Cancer, Clinical Trial Award does not state a per-recipient award amount, open to unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "additional information on eligibility", closing Oct 1, 2026.

Record fields

Program pool (total): $5,600,000
Total across all awards in this programme. Not an amount any single applicant can receive.
Award ceiling (per project): Not confirmed
Award floor: Not confirmed
Typical award: Not confirmed
Deadline: Oct 1, 2026
Deadline type: Fixed date
Opens: May 4, 2026
Status: Closing soon
Eligible entities: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Geography: Not stated
Matching funds: Not confirmed
Disbursement: Not confirmed
Application effort: Not confirmed
Use of funds: clinical trials · evaluate promising new products · pharmacologic agents · devices · clinical guidance · emerging approaches and technologies
Currency: USD

How much money is available?

Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.

Program pool (total)Across all awards this cycle

$5,600,000

Award ceiling (per project)The most one applicant can receive

Not stated

Who can apply?

level

federal

Derived from the source that published this record

entity

Open to any applicant

Source field: entity types

industry

Science, Technology, Research & Development

Source field: industries

use

clinical guidance, clinical trials, devices, emerging approaches and technologies, evaluate promising new products, pharmacologic agents

Source field: use of funds

size limit

Not confirmed

Source field: applicant size limit

clause text

Not confirmed

We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.

When does it close?

Oct 1, 202625 daysDeadline type Fixed date

What can the money be used for?

6 categorysThe source’s own spending categories, and what is not parsed.

clinical trialsevaluate promising new productspharmacologic agentsdevicesclinical guidanceemerging approaches and technologies

These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.

Common questions

4 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.

How much funding is available in total?: $5,600,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
When is the application deadline?: Oct 1, 2026.
Who is eligible to apply?: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".
What can the funding be used for?: clinical trials, evaluate promising new products, pharmacologic agents, devices, clinical guidance, emerging approaches and technologies, as classified by the source.

AI summary of the source text

Optional. Every core field on this record is already above, free and complete.

AI summary of the source text

Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.

Included with Studio

Provenance

Source pagegrants.gov

Retrieved2026-09-04

MethodAutomated check

First seen2026-09-03

The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.